On Tuesday, #Johnson & #Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a #halt to the #drug #pricing #program. Three other drug companies — #Merck, #Bristol #Myers #Squibb and #Astellas #Pharma — have filed their own lawsuits, as have the industry’s main trade group and the U.S. #Chamber of #Commerce.
The suits make similar and overlapping claims that the drug pricing provisions are #unconstitutional. They are scattered in federal courts around the country — a tactic that experts say gives the industry a better chance of obtaining #conflicting #rulings that will put the legal challenges on a fast track to a business-friendly #Supreme #Court.